RhumbLine Advisers’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-51,485
| Closed | -$1.8M | – | 4433 |
|
|
2024
Q1 | $1.8M | Buy |
51,485
+2,338
| +5% | +$81.7K | ﹤0.01% | 1951 |
|
|
2023
Q4 | $1.87M | Buy |
49,147
+322
| +0.7% | +$12.2K | ﹤0.01% | 1945 |
|
|
2023
Q3 | $896K | Sell |
48,825
-1,344
| -3% | -$24.7K | ﹤0.01% | 2270 |
|
|
2023
Q2 | $1.3M | Buy |
50,169
+5,611
| +13% | +$146K | ﹤0.01% | 2160 |
|
|
2023
Q1 | $841K | Buy |
44,558
+3,354
| +8% | +$63.3K | ﹤0.01% | 2205 |
|
|
2022
Q4 | $1.02M | Buy |
41,204
+5,661
| +16% | +$139K | ﹤0.01% | 2122 |
|
|
2022
Q3 | $638K | Buy |
35,543
+2,699
| +8% | +$48.4K | ﹤0.01% | 2380 |
|
|
2022
Q2 | $373K | Buy |
32,844
+4,435
| +16% | +$50.4K | ﹤0.01% | 2641 |
|
|
2022
Q1 | $633K | Buy |
28,409
+3,299
| +13% | +$73.5K | ﹤0.01% | 2313 |
|
|
2021
Q4 | $1.1M | Buy |
25,110
+702
| +3% | +$30.7K | ﹤0.01% | 2170 |
|
|
2021
Q3 | $813K | Buy |
24,408
+2,431
| +11% | +$81K | ﹤0.01% | 2329 |
|
|
2021
Q2 | $605K | Buy |
+21,977
| New | +$605K | ﹤0.01% | 2480 |
|
|
2021
Q1 | – | Sell |
-6,490
| Closed | -$214K | – | 3075 |
|
|
2020
Q4 | $214K | Buy |
+6,490
| New | +$214K | ﹤0.01% | 2811 |
|